Literature DB >> 23768762

CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics.

Zenko Noto1, Toshiko Yoshida, Motonori Okabe, Chika Koike, Moustafa Fathy, Hiroaki Tsuno, Kei Tomihara, Naoya Arai, Makoto Noguchi, Toshio Nikaido.   

Abstract

BACKGROUND: Cancer may be derived from cancer stem-like cells (CSCs), which are tumor-initiating cells that have properties similar to those of stem cells. Identification and isolation of CSCs needs to be improved further.
MATERIALS AND METHODS: CSCs markers were examined in human oral cancer cell lines by flow cytometry. The stem cell properties of subpopulations expressing different markers were assessed further by in vitro sphere formation assays, expression of stemness genes, drug resistance assays, and the ability to form tumors in nude mice.
RESULTS: We demonstrated that CSCs could be isolated by the cell surface markers CD44 and stage-specific embryonic antigen-4 (SSEA-4). CD44+SSEA-4+ cells exhibited cancer stem-like properties, including extensive self-renewal into the bulk of cancer cells. In vivo xenograft experiments indicated that CD44+SSEA-4+ cells exhibit the highest tumorigenic capacity compared with the remaining subpopulations and parental cells. Double-positive cells for CD44 and SSEA-4 exhibited preferential expression of some stemness genes and were more resistant to the anticancer drugs, cisplatin and 5-fluorouracil (5-FU). In addition, cells expressing CD44 and SSEA-4 were detected in all tumor specimens analyzed, while coexpression of CD44 and SSEA-4 was not detectable in normal oral mucosa.
CONCLUSION: Our findings suggest that CD44+SSEA-4+ cells exhibit the characteristics of CSCs in oral squamous cell carcinoma and provide a target for the development of more effective therapies.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD44; Cancer stem-like cells; Oral cancer cell line; SSEA-4

Mesh:

Substances:

Year:  2013        PMID: 23768762     DOI: 10.1016/j.oraloncology.2013.04.012

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  26 in total

Review 1.  Chemotherapy targeting cancer stem cells.

Authors:  Haiguang Liu; Lin Lv; Kai Yang
Journal:  Am J Cancer Res       Date:  2015-02-15       Impact factor: 6.166

2.  Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cells.

Authors:  Kavitha Sivasubramaniyan; Abhishek Harichandan; Karin Schilbach; Andreas F Mack; Jens Bedke; Arnulf Stenzl; Lothar Kanz; Gerhard Niederfellner; Hans-Jörg Bühring
Journal:  Glycobiology       Date:  2015-05-15       Impact factor: 4.313

3.  Surface markers of liver cancer stem cells and innovative targeted-therapy strategies for HCC.

Authors:  Lige Qiu; Hailiang Li; Sirui Fu; Xiaofang Chen; Ligong Lu
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

4.  Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.

Authors:  Yi-Wei Lou; Pao-Yuan Wang; Shih-Chi Yeh; Po-Kai Chuang; Shiou-Ting Li; Chung-Yi Wu; Kay-Hooi Khoo; Michael Hsiao; Tsui-Ling Hsu; Chi-Huey Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

5.  Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.

Authors:  Banu Iskender; Kenan Izgi; Halit Karaca; Halit Canatan
Journal:  J Nat Med       Date:  2015-06-09       Impact factor: 2.343

6.  Ovarian Cancer Stem Cells: Unraveling a Germline Connection.

Authors:  Seema C Parte; Andrei Smolenkov; Surinder K Batra; Mariusz Z Ratajczak; Sham S Kakar
Journal:  Stem Cells Dev       Date:  2017-11-28       Impact factor: 3.272

7.  The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibody.

Authors:  Caroline Soliman; Jia Xin Chua; Mireille Vankemmelbeke; Richard S McIntosh; Andrew J Guy; Ian Spendlove; Lindy G Durrant; Paul A Ramsland
Journal:  J Biol Chem       Date:  2019-12-12       Impact factor: 5.157

8.  Outer brain barriers in rat and human development.

Authors:  Christian B Brøchner; Camilla B Holst; Kjeld Møllgård
Journal:  Front Neurosci       Date:  2015-03-16       Impact factor: 4.677

Review 9.  Increased Oxidative Stress as a Selective Anticancer Therapy.

Authors:  Jiahui Liu; Zhichong Wang
Journal:  Oxid Med Cell Longev       Date:  2015-07-26       Impact factor: 6.543

10.  Combined Effect of Anti-SSEA4 and Anti-Globo H Antibodies on Breast Cancer Cells.

Authors:  Ruey-Herng Lee; Yu-Jen Wang; Ting-Yen Lai; Tsui-Ling Hsu; Po-Kai Chuang; Han-Chung Wu; Chi-Huey Wong
Journal:  ACS Chem Biol       Date:  2021-08-09       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.